IL129662A0 - Composition for the treatment of asthma containing loratadine and a decongestant - Google Patents

Composition for the treatment of asthma containing loratadine and a decongestant

Info

Publication number
IL129662A0
IL129662A0 IL12966297A IL12966297A IL129662A0 IL 129662 A0 IL129662 A0 IL 129662A0 IL 12966297 A IL12966297 A IL 12966297A IL 12966297 A IL12966297 A IL 12966297A IL 129662 A0 IL129662 A0 IL 129662A0
Authority
IL
Israel
Prior art keywords
decongestant
treatment
composition
containing loratadine
asthma containing
Prior art date
Application number
IL12966297A
Other languages
English (en)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of IL129662A0 publication Critical patent/IL129662A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL12966297A 1996-10-31 1997-10-29 Composition for the treatment of asthma containing loratadine and a decongestant IL129662A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31
PCT/US1997/019158 WO1998018470A1 (en) 1996-10-31 1997-10-29 Composition, for the treatment of asthma, containing loratadine and a decongestant

Publications (1)

Publication Number Publication Date
IL129662A0 true IL129662A0 (en) 2000-02-29

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12966297A IL129662A0 (en) 1996-10-31 1997-10-29 Composition for the treatment of asthma containing loratadine and a decongestant

Country Status (21)

Country Link
EP (1) EP0941091A1 (sk)
JP (1) JP2000505104A (sk)
KR (1) KR20000052922A (sk)
CN (1) CN1235545A (sk)
AR (1) AR008908A1 (sk)
AU (1) AU731756B2 (sk)
BR (1) BR9712705A (sk)
CA (1) CA2268546A1 (sk)
CO (1) CO4910128A1 (sk)
CZ (1) CZ150999A3 (sk)
HU (1) HUP9904075A3 (sk)
ID (1) ID23431A (sk)
IL (1) IL129662A0 (sk)
NO (1) NO992062D0 (sk)
NZ (1) NZ335078A (sk)
PE (1) PE11399A1 (sk)
PL (1) PL333056A1 (sk)
SK (1) SK54599A3 (sk)
TR (1) TR199901003T2 (sk)
WO (1) WO1998018470A1 (sk)
ZA (1) ZA979731B (sk)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AR022378A1 (es) * 1998-09-10 2002-09-04 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
MXPA03011705A (es) * 2001-06-20 2004-03-19 Schering Corp Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal.
AU2005333081B2 (en) * 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP2366381A1 (en) * 2006-06-01 2011-09-21 MSD Consumer Care, Inc. Phenylephrine pharmaceutical formulations and compositions for colonic absorption
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
HUP9904075A3 (en) 2002-02-28
EP0941091A1 (en) 1999-09-15
CO4910128A1 (es) 2000-04-24
CZ150999A3 (cs) 1999-10-13
KR20000052922A (ko) 2000-08-25
BR9712705A (pt) 1999-10-26
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
JP2000505104A (ja) 2000-04-25
PE11399A1 (es) 1999-02-09
CA2268546A1 (en) 1998-05-07
AR008908A1 (es) 2000-02-23
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
ID23431A (id) 2000-04-20
TR199901003T2 (xx) 1999-07-21
NO992062L (no) 1999-04-29
SK54599A3 (en) 2000-08-14
CN1235545A (zh) 1999-11-17
AU4995397A (en) 1998-05-22
PL333056A1 (en) 1999-11-08
NO992062D0 (no) 1999-04-29

Similar Documents

Publication Publication Date Title
NZ294392A (en) Asthma drugs and compounds
IL132424A0 (en) Prescription compliance device and method of using the device
EP0769974A4 (en) IMPROVED INHALER AND PACKAGING FOR MEDICINES
AU119600S (en) Inhaler device
HRP960365B1 (en) New medicaments and the use thereof
IL129662A0 (en) Composition for the treatment of asthma containing loratadine and a decongestant
EP0803255A4 (en) DRUG
HUT77918A (hu) Berendezés és alkalmazása oxiklórozáshoz
IL125775A0 (en) Use of a zwitterion composition and a pharmaceutical composition containing the same
AU2621195A (en) Dental implant material and positioning device
IL116190A0 (en) Eleutherobin and analogs thereof
IL130348A0 (en) Imidazopyridazines and medicaments containing the same
GB9424499D0 (en) Game and associated apparatus
HUP9701618A3 (en) Pharmaceutical composition containing tramadol and a calcium-canal-antagonist
GB9522178D0 (en) Material treatment
GB9415901D0 (en) Novel compounds and treatment
GB2355006B (en) Materials treatment
EP0799225A4 (en) COMPOUNDS AND RELATED METHODS
GB9415900D0 (en) Novel compounds and treatment
ZA951226B (en) The treatment of gaseous substances
IL102415A0 (en) Apparatus and techniques for manufacturing insoles
GB9617346D0 (en) Therapeutic methods and compositions for use therein
GB9413076D0 (en) Composition and use
HUP0003908A3 (en) Use of substituted azaspirane in the manufacture of a medicament for use in treating asthma
IL115853A0 (en) Aryloxycycloalkenyl and aryloxyiminocyclo-alkenylhydroxyureas